As happened initially with the tirzepatide suit, the FDA isnt going after any semaglutide compounders until the judge makes a call, leaving options available for now
Pharmacy-based distribution accounts for 44% of medication access, while hospital applications contribute 56% of treatment usage
Patients should be prepared to discuss medical history, current medications, previous treatments, wellness goals, and recent lab work if available
Rybarczyk-Mydowska K, van Megen H, van den Elsen S, Mooyman P, Karssen G, Bakker J, et al
Ozempic heart palpitations are a known side effect for some people on semaglutide or other GLP-1 medications, showing up as fluttering, a racing pulse, or irregular beats that raise anxiety
Take the Assessment A subscription receipt showing what you paid